News
Palantir Technologies • PLTR-Nasdaq Hold • $160.66 on Aug. 4 by Deutsche Bank Palantir delivered another impressive result, ...
Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount of weight, the company said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results